AstroNova Reports Fiscal 2025 Second Quarter Financial Results

Rhea-AI Summary

AstroNova (NASDAQ: ALOT) reported its fiscal 2025 Q2 results, showing revenue growth of 14.1% year-over-year to $40.5 million. The company saw improvements in both its Product Identification (PI) and Test & Measurement (T&M) segments. Gross margin increased to 35.3%, up 800 basis points from the previous year. However, the company reported a net loss of $(0.04) per share, compared to $(0.22) in Q2 FY2024. Non-GAAP diluted EPS was $0.08.

The company's recent acquisition of MTEX NS is still in the integration phase, contributing $0.8 million in revenue but an operating loss of $1.4 million. AstroNova expects MTEX to meet its target revenue contribution of $8-10 million for FY2025. The company has revised its FY2025 Adjusted EBITDA margin estimate to 9-10% due to the MTEX integration.

Positive

• Revenue increased by 14.1% year-over-year to $40.5 million
• Gross margin improved by 800 basis points to 35.3%
• Test & Measurement segment revenue grew 37.2% year-over-year
• Adjusted EBITDA increased by 5.3% to $3.9 million
• Bookings increased to $35.8 million from $30.1 million in Q2 FY2024

Negative

• Net loss of $(0.04) per share compared to $(0.22) in Q2 FY2024
• MTEX NS acquisition contributed an operating loss of $1.4 million
• Reduced FY2025 Adjusted EBITDA margin estimate to 9-10% due to MTEX integration
• Non-GAAP diluted EPS decreased to $0.08 from $0.15 in Q2 FY2024
• Backlog decreased to $29.9 million from $31.6 million at the end of Q1 FY2025

Insights

Financial Analyst

AstroNova's Q2 FY2025 results show mixed signals. Revenue growth of 14.1% year-over-year to $40.5 million is impressive, driven by both PI and T&M segments. The 800 basis point improvement in GAAP gross margin to 35.3% is significant. However, non-GAAP gross margin remained flat at 35.6%, indicating underlying cost pressures.

The $1.1 million GAAP operating income is a positive turnaround from last year's loss, but non-GAAP operating margin decreased by 100 basis points. The reduction in non-GAAP EPS from $0.15 to $0.08 is concerning, suggesting challenges in maintaining profitability despite revenue growth.

The MTEX NS acquisition's slow start ($0.8 million revenue, $1.4 million operating loss) is a short-term drag but could provide long-term benefits if successfully integrated. The revised Adjusted EBITDA margin guidance of 9-10% for FY2025 reflects these integration challenges.

Market Research Analyst

AstroNova's Q2 results reveal interesting market dynamics. The Product Identification segment's 5% YoY and 17% sequential growth indicates robust demand in labeling and packaging. The Test & Measurement segment's 37% growth, both sequentially and YoY, suggests a strong rebound in aerospace activities.

Bookings increased from $30.1 million to $35.8 million YoY, primarily in T&M, indicating positive industry trends. However, the backlog decrease from $31.6 million to $29.9 million quarter-over-quarter suggests improved supply chain efficiency but potential softening in new orders.

The MTEX NS acquisition, while currently underperforming, positions AstroNova in the growing digital textile printing market. The $8-10 million revenue target for FY2025 from MTEX indicates management's confidence in this market's potential. Investors should monitor the integration progress and its impact on overall company performance.

Tech Expert

AstroNova's technological positioning appears promising, particularly with the MTEX NS acquisition. The company's focus on integrating MTEX's ink and printhead technologies into their Product Identification products could be a game-changer, potentially leading to enhanced product offerings and market differentiation.

The company's commitment to innovative, high-margin products is evident in their growth strategy. The strong performance in the Aerospace product line within the T&M segment suggests successful technological adaptation to market demands.

However, the integration challenges with MTEX highlight the complexities of merging different technological ecosystems. The projected timeline to fully integrate MTEX's systems and processes into the AstroNova Operating System by the end of fiscal 2025 is crucial. Successful integration could unlock significant synergies and drive future growth, but delays or complications could impact short-term performance and investor confidence.

Company to host conference call at 9:30 a.m. ET today

• Revenue of $40.5 million, up 14.1% year over year
• Gross margin of 35.3%, up 800 basis points year over year; non-GAAP gross margin of 35.6%, unchanged year over year
• Operating income of $1.1 million; non-GAAP operating income of $2.2 million
• Net loss per share of $(0.04) vs. $(0.22) in the second quarter of fiscal year 2024; non-GAAP diluted earnings per share of $0.08 vs. $0.15 in the second quarter of fiscal 2024
• Adjusted EBITDA of $3.9 million, up 5.3% year over year

WEST WARWICK, R.I.--(BUSINESS WIRE)-- AstroNova, Inc. (Nasdaq: ALOT), a global leader in data visualization technologies, today announced financial results for its fiscal 2025 second quarter ended August 3, 2024.

CEO Commentary

“We demonstrated the resilience of our Product Identification (PI) and Test & Measurement (T&M) segments during a second quarter in which we began shipping a previously delayed order and benefited from the resolution of supply chain shortages,” said Greg Woods, AstroNova’s President and Chief Executive Officer. “In PI, total revenue increased more than 5% year-over-year and more than 17% sequentially, driven primarily by organic growth. T&M revenue grew 37% sequentially and year-over-year, reflecting continued momentum from our Aerospace product line.

“During the quarter we began the process of integrating our May acquisition of MTEX NS. Because MTEX was an entrepreneurial, private company, the integration got off to a slow start in the quarter, generating revenue of only $0.8 million and an operating loss of $1.4 million. We expect it to take through the remainder of fiscal 2025 to transition MTEX’s systems, processes and business tools to those of the AstroNova Operating System,” Woods said. “We remain excited about MTEX’s core strengths, including its engineering and manufacturing capabilities and especially its game-changing ink and printhead technologies. In the coming months we will be devoting additional resources to integrating that technology into more of our Product Identification products. Buoyed by several large tradeshows since the acquisition, MTEX has built a strong product backlog that we expect to begin shipping in the third and fourth quarters, which will enable the business to meet our target revenue contribution of $8 million to $10 million for full-year fiscal 2025.”

Business Outlook

“Looking ahead, we are optimistic about our growth prospects,” Woods continued. “We are well-positioned to continue driving organic growth, supported by our commitment to delivering innovative, high-margin products while maintaining strong cost controls. We anticipate achieving our fiscal year targets for revenue growth. As a result of the MTEX integration, we have reduced our consolidated FY 2025 Adjusted EBITDA margin estimate to a range of 9% to 10% and expect to be within the range of 13% to 14% in fiscal 2026.”

Q2 FY 2025 Financial Results

		GAAP						Non-GAAP
($ in thousands except per share data)		Q2 FY25		Q2 FY24		YoY		Q2 FY25		Q2 FY24		YoY
Revenue		$40,539		$35,524		14.1%
Gross Profit		$14,326		$9,710		47.5%		$14,446		$12,659		14.1%
Gross Margin		35.3%		27.3%		800 pts		35.6%		35.6%		-
Operating Margin		2.6%		(3.4%)		600 pts		5.5%		6.5%		(100 pts)
Net (Loss) Income		$(311)		$(1,617)		-		$572		$1,089		(47.5%)
Net (Loss) Income Per Common Share		$(0.04)		$(0.22)		-		$0.08		$0.15		(46.7%)
See reconciliation tables GAAP to Non-GAAP reconciliations.

Adjusted EBITDA was $3.9 million for the second quarter of fiscal 2025, compared with $3.7 million in the comparable period of fiscal 2024. Adjusted EBITDA for the fiscal 2025 period excludes the impact of $1.7 million in costs related to stock-based compensation, CFO transition and MTEX acquisition-related expenses. Adjusted EBITDA for the fiscal 2024 period excludes the impact of stock-based compensation, retrofit and restructuring costs of $3.9 million.

Bookings for the second quarter of fiscal 2025 were $35.8 million compared with $30.1 million in the second quarter of fiscal 2024. Bookings were primarily higher in the Test and Measurement segment.

Backlog as of August 3, 2024, was $29.9 million, compared with $31.6 million at the end of the first quarter of fiscal 2025, as some shipments delayed in the first quarter were shipped in the second quarter.

Q2 FY 2025 Operating Segment Results

Product Identification

PI segment revenue was $27.2 million in the second quarter of fiscal 2025, compared with $25.8 million in the second quarter of 2024, reflecting organic growth and the addition of MTEX NS. Segment operating profit was $2.3 million, or 8.6% of revenue, compared with a segment operating loss of $461,000, or (1.8%) of revenue, in the same period last year. Excluding the results of MTEX in fiscal 2025 and certain expenses in both periods (see reconciliation tables below for GAAP reconciliation), non-GAAP operating profit was $3.6 million, or 13.7% of revenue in the fiscal 2025 period, compared with non-GAAP operating profit of $3.0 million, or 11.5% of revenue, in the same period of fiscal 2024.

Test & Measurement

Test & Measurement (T&M) segment revenue was $13.4 million in the second quarter of fiscal 2025, compared with $9.7 million in the same period of fiscal 2024, representing a 37.2% increase. Segment operating profit was $3.8 million, or 28.7% of revenue, in the second quarter of fiscal 2025 compared with $1.9 million, or 19.7% of revenue, in the second quarter of fiscal 2024. This improvement reflected higher revenue and $1.3 million in revenue and $1.0 million in operating profit related to non-recurring items.

Earnings Conference Call Information

AstroNova will discuss its fiscal 2025 second quarter financial results in an investor conference call at 9:30 a.m. ET today. To access the conference call, please dial (833) 470-1428 (U.S. and Canada) or (404) 975-4839 (International) approximately 10 minutes prior to the start time and enter access code 381674. A real-time and an archived audio webcast of the call will be available through the “Investors” section of the AstroNova website, https://investors.astronovainc.com.

Use of Non-GAAP Financial Measures

In addition to financial measures prepared in accordance with generally accepted accounting principles (GAAP), this news release contains the non-GAAP financial measures non-GAAP gross profit, non-GAAP gross margin, non-GAAP operating income, non-GAAP operating margin, non-GAAP net income, non-GAAP net income (loss) per common share and Adjusted EBITDA. AstroNova believes that the inclusion of these non-GAAP financial measures helps investors gain a meaningful understanding of changes in the Company’s core operating results and can help investors who wish to make comparisons between AstroNova and other companies on both a GAAP and a non-GAAP basis. AstroNova’s management uses these non-GAAP financial measures, in addition to GAAP financial measures, as the basis for measuring its core operating performance and comparing such performance to that of prior periods and to the performance of its competitors. These measures are also used by the Company’s management to assist with their financial and operating decision-making. Please refer to the financial reconciliation table included in this news release for a reconciliation of the non-GAAP measures to the most directly comparable GAAP measures for the three months ended August 3, 2024, and July 29, 2023.

AstroNova has not reconciled the forward-looking Adjusted EBITDA growth percentage included in its 2025 financial targets and outlook to the most directly comparable forward-looking GAAP measure because this cannot be done without unreasonable effort due to the lack of predictability regarding cost of sales, operating expenses, depreciation and amortization, and stock-based compensation. The impact of any of these items, individually or in the aggregate, may be significant.

About AstroNova

AstroNova (Nasdaq: ALOT), a global leader in data visualization technologies since 1969, designs, manufactures, distributes, and services a broad range of products that acquire, store, analyze, and present data in multiple formats.

The Product Identification segment provides a wide array of digital, end-to-end product marking and identification solutions, including hardware, software, and supplies for OEMs, commercial printers, and brand owners. The Test and Measurement segment provides products designed for airborne printing solutions, avionics, and data acquisition. Our aerospace products include flight deck printing solutions, networking hardware, and specialized aerospace-grade supplies. Our data acquisition systems are used in research and development, flight testing, missile and rocket telemetry production monitoring, power, and maintenance applications.

AstroNova is a member of the Russell Microcap® Index and the LD Micro Index (INDEXNYSEGIS: LDMICRO). Additional information is available by visiting https://astronovainc.com/.

Forward-Looking Statements

Information included in this news release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not statements of historical fact, but rather reflect our current expectations concerning future events and results. These statements may include the use of the words “believes,” “expects,” “intends,” “plans,” “anticipates,” “likely,” “continues,” “may,” “will,” and similar expressions to identify forward-looking statements. Such forward-looking statements, including those concerning the Company’s anticipated performance, involve risks, uncertainties and other factors, some of which are beyond our control, which may cause our actual results, performance or achievements to be materially different from those expressed or implied by such forward-looking statements. These risks, uncertainties and factors include, but are not limited to, (i) the risk that we may not be able to realize the expected synergies from our acquisition of MTEX NS, (ii) the risk that apparent improvements in the Aerospace sector may not continue, (iii) the risk that supply chain issues may persist longer than we expect, (iv) the risk that we may not be able to incorporate customer-requested design enhancements into our products on the timeframe that we expect or at all, (v) the risk that we may not be able to ship delayed hardware items on the timeline we expect or at all, and (vi) those factors set forth in the Company’s Annual Report on Form 10-K for the fiscal year ended January 31, 2024 and subsequent filings AstroNova makes with the Securities and Exchange Commission. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. The reader is cautioned not to unduly rely on such forward-looking statements when evaluating the information presented in this news release.

ASTRONOVA, INC.
Condensed Consolidated Statements of Income
In Thousands Except for Per Share Data
(Unaudited)
		Three Months Ended
		August 3, 2024				July 29, 2023
Net Revenue		$	40,539			$	35,524
Cost of Revenue			26,213				25,814
Gross Profit			14,326				9,710
Total Gross Profit Margin			35.3	%			27.3	%
Operating Expenses:
Selling & Marketing			6,732				6,697
Research & Development			1,412				1,557
General & Administrative			5,121				2,654
Total Operating Expenses			13,265				10,908
Operating Income (Loss)			1,061				(1,198	)
Total Operating Margin			2.6	%			(3.4	)%
Other Expense, net			1,111				809
Income (Loss) Before Taxes			(50	)			(2,007	)
Income Tax Provision (Benefit)			261				(390	)
Net Income (Loss)		$	(311	)		$	(1,617	)
Net Income (Loss) per Common Share - Basic		$	(0.04	)		$	(0.22	)
Net Income (Loss) per Common Share - Diluted		$	(0.04	)		$	(0.22	)
Weighted Average Number of Common Shares - Basic			7,516				7,420
Weighted Average Number of Common Shares - Diluted			7,516				7,420
		Six Months Ended
		August 3, 2024				July 29, 2023
Net Revenue		$	73,500			$	70,943
Cost of Revenue			47,202				48,847
Gross Profit			26,298				22,096
Total Gross Profit Margin			35.8	%			31.1	%
Operating Expenses:
Selling & Marketing			12,388				12,707
Research & Development			3,015				3,345
General & Administrative			8,488				5,780
Total Operating Expenses			23,891				21,832
Operating Income			2,407				264
Total Operating Margin			3.3	%			0.4	%
Other Expense, net			1,711				1,244
Income (Loss) Before Taxes			696				(980	)
Income Tax Provision (Benefit)			(173	)			(211	)
Net Income (Loss)		$	869			$	(769	)
Net Income (Loss) per Common Share - Basic		$	0.12			$	(0.10	)
Net Income (Loss) per Common Share - Diluted		$	0.11			$	(0.10	)
Weighted Average Number of Common Shares - Basic			7,489				7,396
Weighted Average Number of Common Shares - Diluted			7,617				7,396

ASTRONOVA, INC.
Consolidated Balance Sheets
In Thousands
(Unaudited)
		August 3, 2024				January 31, 2024
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents		$	4,824			$	4,527
Accounts Receivable, net			23,450				23,056
Inventories, net			50,569				46,371
Prepaid Expenses and Other Current Assets			4,218				2,720
Total Current Assets			83,061				76,674
PROPERTY, PLANT AND EQUIPMENT			69,215				57,046
Less Accumulated Depreciation			(50,465	)			(42,861	)
Property, Plant and Equipment, net			18,750				14,185
OTHER ASSETS
Intangible Assets, net			27,314				18,836
Goodwill			25,368				14,633
Deferred Tax Assets			10,854				6,882
Right of Use Asset			1,920				603
Other Assets			1,750				1,438
TOTAL ASSETS		$	169,017			$	133,251
LIABILITIES AND SHAREHOLDERS’ EQUITY
CURRENT LIABILITIES
Accounts Payable		$	10,456			$	8,068
Accrued Compensation			3,577				2,923
Other Liabilities and Accrued Expenses			4,369				2,706
Revolving Line of Credit			13,354				8,900
Current Portion of Long-Term Debt			6,513				2,842
Short-Term Debt			3,092				-
Current Portion of Royalty Obligation			1,575				1,700
Current Liability – Excess Royalty Payment Due			798				935
Income Taxes Payable			-				349
Deferred Revenue			785				1,338
Total Current Liabilities			44,519				29,761
NON-CURRENT LIABILITIES
Long-Term Debt, net of current portion			22,675				10,050
Royalty Obligation, net of current portion			1,663				2,093
Lease Liability, net of current portion			1,633				415
Grant Deferred Revenue			1,476				-
Contingent Liability Earn Out			1,629				-
Income Tax Payables			551				551
Deferred Tax Liabilities			3,121				99
TOTAL LIABILITIES			77,267				42,969
SHAREHOLDERS’ EQUITY
Common Stock			546				541
Additional Paid-in Capital			63,563				62,684
Retained Earnings			64,739				63,869
Treasury Stock			(35,025	)			(34,593	)
Accumulated Other Comprehensive Loss, net of tax			(2,073	)			(2,219	)
TOTAL SHAREHOLDERS’ EQUITY			91,750				90,282
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY		$	169,017			$	133,251

ASTRONOVA, INC.
Condensed Consolidated Statements of Cash Flows
(In Thousands)
(Unaudited)
		Six Months Ended
		August 3, 2024				July 29, 2023
Cash Flows from Operating Activities:
Net Income (Loss)		$	869			$	(769	)
Adjustments to Reconcile Net Income to Net Cash Provided by Operating Activities:
Depreciation and Amortization			2,216				2,144
Amortization of Debt Issuance Costs			14				11
Share-Based Compensation			806				754
Restructuring - non-cash			-				2,040
Changes in Assets and Liabilities, net of impact of acquisition:
Accounts Receivable			3,612				3,612
Inventories			(384	)			283
Income Taxes			(721	)			(1,461	)
Accounts Payable and Accrued Expenses			2,409				(2,267	)
Deferred Revenue			(619	)			-
Other			(1,136	)			371
Net Cash Provided by Operating Activities			7,066				4,718
Cash Flows from Investing Activities:
Purchases of Property, Plant and Equipment			(830	)			(494	)
Cash Paid for MTEX Acquisition, net of cash acquired			(20,729	)			-
Net Cash Provided (Used) for Investing Activities			(21,559	)			(494	)
Cash Flows from Financing Activities:
Net Cash Proceeds from Employee Stock Option Plans			13				71
Net Cash Proceeds from Share Purchases under Employee Stock Purchase Plan			65				54
Net Cash Used for Payment of Taxes Related to Vested Restricted Stock			(432	)			(350	)
Borrowings under Revolving Credit Facility			3,912				-
Repayment under Revolving Credit Facility			-				(2,000	)
Proceeds from Long-Term Debt Borrowings			15,078				-
Payment of Minimum Guarantee Royalty Obligation			(750	)			(875	)
Principal Payments of Long-Term Debt			(3,274	)			(750	)
Payments of Debt Issuance Costs			(35	)			-
Net Cash Provided (Used) for Financing Activities			14,577				(3,850	)
Effect of Exchange Rate Changes on Cash and Cash Equivalents			213				210
Net Increase in Cash and Cash Equivalents			297				584
Cash and Cash Equivalents, Beginning of Period			4,527				3,946
Cash and Cash Equivalents, End of Period		$	4,824			$	4,530
Supplemental Disclosures of Cash Flow Information:
Cash Paid During the Period for:
Cash Paid During the Period for Interest		$	1,008			$	1,184
Cash Paid During the Period for Income Taxes, net of refunds		$	540			$	1,264
Non-Cash Transactions:
Capital Lease Obtained in Exchange for Capital Lease Liabilities		$	1,455			$	—

ASTRONOVA, INC.
Revenue and Segment Operating Profit
In Thousands
(Unaudited)
		Revenue						Segment Operating Profit
		Three Months Ended						Three Months Ended
		August 3, 2024			July 29, 2023			August 3, 2024				July 29, 2023
Product Identification		$	27,165		$	25,777		$	2,348			$	(461	)
Test & Measurement			13,374			9,747			3,834				1,917
Total		$	40,539		$	35,524			6,182				1,456
Corporate Expenses									5,121				2,654
Operating Income (Loss)									1,061				(1,198	)
Other Expense, net									1,111				809
Income (Loss) Before Income Taxes									(50	)			(2,007	)
Income Tax Provision (Benefit)									261				(390	)
Net Income (Loss)								$	(311	)		$	(1,617	)
		Revenue						Segment Operating Profit
		Six Months Ended						Six Months Ended
		August 3, 2024			July 29, 2023			August 3, 2024				July 29, 2023
Product Identification		$	50,350		$	50,872		$	5,340			$	2,055
Test & Measurement			23,150			20,071			5,555				3,989
Total		$	73,500		$	70,943			10,895				6,044
Corporate Expenses									8,488				5,780
Operating Income									2,407				264
Other Expense, net									1,711				1,244
Income (Loss) Before Income Taxes									696				(980	)
Income Tax Provision (Benefit)									(173	)			(211	)
Net Income (Loss)								$	869			$	(769	)

ASTRONOVA, INC.
Reconciliation of GAAP to Non-GAAP Items
In Thousands Except for Per Share Data
(Unaudited)
		Three Months Ended
		August 3, 2024				July 29, 2023
Gross Profit		$	14,326			$	9,710
Inventory Step-Up			120				-
Restructuring Charges			-				2,096
Product Retrofit Costs			-				852
Non-GAAP Gross Profit		$	14,446			$	12,658
Operating Expenses		$	13,265			$	10,908
MTEX-related Acquisition Expenses			(625	)			-
CFO Transition Costs			(432	)			-
Restructuring Charges			-				(555	)
Non-GAAP Operating Expenses		$	12,208			$	10,353
Operating Income (Loss)		$	1,061			$	(1,198	)
MTEX-related Acquisition Expenses			625				-
CFO Transition Costs			432				-
Inventory Step-Up			120				-
Restructuring Charges			-				2,651
Product Retrofit Costs			-				852
Non-GAAP Operating Income		$	2,238			$	2,305
Net Income (Loss)		$	(311	)		$	(1,617	)
MTEX-related Acquisition Expenses, net			470				-
CFO Transition Costs, net			328				-
Inventory Step-Up, net			85				-
Restructuring Charges, net			-				2,048
Product Retrofit Costs, net			-				658
Non-GAAP Net Income		$	572			$	1,089
Diluted Earnings (Loss) Per Share		$	(0.04	)		$	(0.22	)
MTEX-related Acquisition Expenses			0.06				-
CFO Transition Costs			0.05				-
Inventory Step-Up			0.01				-
Restructuring Charges			-				0.28
Product Retrofit Costs			-				0.09
Non-GAAP Diluted Earnings (Loss) Per Share		$	0.08			$	0.15
		Six Months Ended
		August 3, 2024				July 29, 2023
Gross Profit		$	26,298			$	22,096
Inventory Step-Up			120				-
Restructuring Charges			-				2,096
Product Retrofit Costs			-				852
Non-GAAP Gross Profit		$	26,418			$	25,044
Operating Expenses		$	23,891			$	21,832
MTEX-related Acquisition Expenses			(625	)			-
CFO Transition Costs			(432	)			-
Restructuring Charges			-				(555	)
Non-GAAP Operating Expenses		$	22,834			$	21,277
Operating Income		$	2,407			$	264
MTEX-related Acquisition Expenses			625				-
CFO Transition Costs			432				-
Inventory Step-Up			120				-
Restructuring Charges			-				2,651
Product Retrofit Costs			-				852
Non-GAAP Operating Income		$	3,584			$	3,767
Net Income (Loss)		$	869			$	(769	)
MTEX-related Acquisition Expenses, net			470				-
CFO Transition Costs, net			328				-
Inventory Step-Up, net			85				-
Restructuring Charges, net			-				2,048
Product Retrofit Costs, net			-				658
Non-GAAP Net Income		$	1,752			$	1,937
Diluted Earnings (Loss) Per Share		$	0.11			$	(0.10	)
MTEX-related Acquisition Expenses			0.06				-
CFO Transition Costs			0.05				-
Inventory Step-Up			0.01				-
Restructuring Charges			-				0.28
Product Retrofit Costs			-				0.09
Non-GAAP Diluted Earnings Per Share		$	0.23			$	0.27

ASTRONOVA, INC.
Reconciliation of GAAP to Non-GAAP Items for PI Segment
Amounts In Thousands
(Unaudited)
	Q2 FY25																		Q2 FY24
	Total PI Segment as Reported			MTEX As Reported				Inventory Step Up				Adj MTEX (Non Gaap)				PI Excluding MTEX (Non Gaap)			Total PI Segment as Reported				Restructuring and Product Retrofit Adjustments				Total PI Segment (Non Gaap)
Sales	$	27,165		$	768			$	-			$	768			$	26,397		$	25,777			$	-			$	25,777
Cost of Revenue		18,544			836				(120	)			716				17,828			19,487				(2,948	)			16,539
Gross Profit		8,621			(68	)			120				52				8,569			6,290				2,948				9,238
Operating Expenses		6,273			1,328				-				1,328				4,945			6,751				(472	)			6,279
Segment Operating Profit	$	2,348		$	(1,396	)		$	120			$	(1,276	)		$	3,624		$	(461	)		$	3,420			$	2,959

ASTRONOVA, INC.
Reconciliation of Net Income (Loss) to Adjusted EBITDA
Amounts In Thousands
(Unaudited)
		Three Months Ended
		August 3, 2024				July 29, 2023
Net Income (Loss)		$	(311	)		$	(1,617	)
Interest Expense			938				674
Income Tax Expense (Benefit)			261				(390	)
Depreciation & Amortization			1,305				1,089
EBITDA		$	2,193			$	(244	)
Share-Based Compensation			481				398
MTEX-related Acquisition Expenses			625				-
CFO Transition Costs			432				-
Inventory Step-Up			120				-
Restructuring Charges			-				2,651
Product Retrofit Costs			-				852
Adjusted EBITDA		$	3,851			$	3,657
		Six Months Ended
		August 3, 2024				July 29, 2023
Net Income (Loss)		$	869			$	(769	)
Interest Expense			1,419				1,289
Income Tax Expense (Benefit)			(173	)			(211	)
Depreciation & Amortization			2,216				2,144
EBITDA		$	4,331			$	2,453
Share-Based Compensation			806				754
MTEX-related Acquisition Expenses			625				-
CFO Transition Costs			432				-
Inventory Step-Up			120				-
Restructuring Charges			-				2,651
Product Retrofit Costs			-				852
Adjusted EBITDA		$	6,314			$	6,710

ASTRONOVA, INC.
Reconciliation of Segment Operating Income (Loss) to Non-GAAP Operating Income
Amounts In Thousands
(Unaudited)
		Three Months Ended
		August 3, 2024									July 29, 2023
		Product Identification			Test & Measurement			Total			Product Identification				Test & Measurement			Total
Segment Operating Profit (Loss)		$	2,348		$	3,834		$	6,182		$	(461	)		$	1,917		$	1,456
Inventory Step-Up			120			-			120			-				-			-
Restructuring Charges			-			-			-			2,568				-			2,568
Product Retrofit Costs			-			-			-			852				-			852
Non-GAAP - Segment Operating Profit		$	2,468		$	3,834		$	6,302		$	2,959			$	1,917		$	4,876
		Six Months Ended
		August 3, 2024									July 29, 2023
		Product Identification			Test & Measurement			Total			Product Identification				Test & Measurement			Total
Segment Operating Profit		$	5,340		$	5,555		$	10,895		$	2,055			$	3,989		$	6,044
Inventory Step-Up			120			-			120			-				-			-
Restructuring Charges			-			-			-			2,568				-			2,568
Product Retrofit Costs			-			-			-			852				-			852
Non-GAAP - Segment Operating Profit		$	5,460		$	5,555		$	11,015		$	5,475			$	3,989		$	9,464

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20240916638067/en/

Scott Solomon

Senior Vice President

Sharon Merrill Advisors

(857) 383-2409

ALOT@investorrelations.com

Source: AstroNova

FAQ

What was AstroNova's (ALOT) revenue for Q2 fiscal 2025?

AstroNova's revenue for Q2 fiscal 2025 was $40.5 million, representing a 14.1% increase year-over-year.

How did AstroNova's (ALOT) gross margin change in Q2 fiscal 2025?

AstroNova's gross margin improved to 35.3% in Q2 fiscal 2025, up 800 basis points from the same period last year.

What was the performance of AstroNova's (ALOT) Test & Measurement segment in Q2 fiscal 2025?

The Test & Measurement segment revenue grew 37.2% year-over-year to $13.4 million in Q2 fiscal 2025.

How much did MTEX NS contribute to AstroNova's (ALOT) Q2 fiscal 2025 results?

MTEX NS contributed $0.8 million in revenue but resulted in an operating loss of $1.4 million for AstroNova in Q2 fiscal 2025.

What is AstroNova's (ALOT) revised Adjusted EBITDA margin estimate for fiscal 2025?

AstroNova revised its fiscal 2025 Adjusted EBITDA margin estimate to a range of 9% to 10% due to the MTEX integration.